Targeted delivery of adenosine 5'-triphosphate using chitosan-coated mesoporous hydroxyapatite: A theranostic pH-sensitive nanoplatform with enhanced anti-cancer effect.
Adenosine Triphosphate
/ chemistry
Adsorption
Antineoplastic Agents
/ chemistry
Biological Transport
Cell Line, Tumor
Chitosan
/ chemistry
Drug Carriers
/ chemistry
Durapatite
/ chemistry
Humans
Hydrogen-Ion Concentration
Kinetics
Nanoparticles
/ chemistry
Porosity
Surface Properties
Theranostic Nanomedicine
Adenosine 5′-triphosphate
Chitosan
Mesoporous hydroxyapatite
Journal
International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578
Informations de publication
Date de publication:
15 May 2019
15 May 2019
Historique:
received:
24
06
2018
revised:
28
07
2018
accepted:
27
08
2018
pubmed:
1
9
2018
medline:
25
7
2019
entrez:
1
9
2018
Statut:
ppublish
Résumé
In this Study, a pH-sensitive nanoplatform made up of chitosan (Cs) and mesoporous hydroxyapatite (HAP) was synthesized and employed for delivering of adenosine 5'-triphosphate (ATP). The fabricated system was decorated with folic acid (FA), providing both tumor targeting and imaging. The FA.Cs.ATP@HAP nanoparticles displayed enhanced colloidal stability and controlled drug release. In vitro biological experiments revealed that FA.Cs.ATP@HAP was internalized into the tumor cells with a high efficiency in a time-dependent manner and exhibited strong fluorescence within the cells. Compared with free ATP, the FA.Cs.ATP@HAP nanoparticles exhibited a significant inhibition effect against the proliferation of the tumor cells (Saos-2, T47D, and MCF7) in a dose-dependent manner, while no significant cytotoxic effect was observed in the normal cells (HEK-293), indicating the selective cytotoxicity of the fabricated nanosystem against the tumor cells. Also, the mechanism of action of FA.Cs.ATP@HAP was investigated, and it was found that it induces a high rate of apoptosis in the tumor cells through a decrease in mitochondrial membrane potential and caspase activation. Based on these findings, FA.Cs.ATP@HAP is a novel biomedical material with targeting, imaging, and high anticancer properties against tumor cells, and it could be considered as a promising candidate for cancer therapy.
Identifiants
pubmed: 30170062
pii: S0141-8130(18)33138-6
doi: 10.1016/j.ijbiomac.2018.08.158
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Drug Carriers
0
Adenosine Triphosphate
8L70Q75FXE
Chitosan
9012-76-4
Durapatite
91D9GV0Z28
Types de publication
Journal Article
Langues
eng
Pagination
1090-1102Informations de copyright
Copyright © 2018 Elsevier B.V. All rights reserved.